GE HealthCare Board Changes and Officer Compensation Update

Ticker: GEHC · Form: 8-K · Filed: 2024-04-15T00:00:00.000Z

Sentiment: neutral

Topics: board-of-directors, executive-compensation, management-change

Related Tickers: GEHC

TL;DR

GE HealthCare adds two directors, loses one, and adjusts CFO pay.

AI Summary

GE HealthCare Technologies Inc. announced changes to its Board of Directors on April 9, 2024. Effective April 15, 2024, Michael J. Barber and Philip M. Gresh will join the Board, while Margaret L. Knight will depart. Additionally, the company has entered into a new compensatory arrangement with its Chief Financial Officer, Brian G. Gallagher.

Why It Matters

Changes in board composition can signal shifts in strategic direction or governance, while updates to executive compensation are closely watched by investors for alignment with company performance.

Risk Assessment

Risk Level: low — The filing details routine board and compensation adjustments, which are common corporate events.

Key Players & Entities

FAQ

Who are the new directors joining GE HealthCare's Board?

Michael J. Barber and Philip M. Gresh are joining the Board of Directors.

Who is departing the GE HealthCare Board?

Margaret L. Knight is departing the Board of Directors.

When are the board changes effective?

The board changes are effective as of April 15, 2024.

What is the date of the earliest event reported in this filing?

The earliest event reported is dated April 9, 2024.

What other item is reported in this 8-K besides director changes?

The filing also reports on a compensatory arrangement for the Chief Financial Officer, Brian G. Gallagher.

From the Filing

0001932393-24-000027.txt : 20240415 0001932393-24-000027.hdr.sgml : 20240415 20240415170037 ACCESSION NUMBER: 0001932393-24-000027 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240409 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240415 DATE AS OF CHANGE: 20240415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 24845313 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 gehc-20240409.htm 8-K gehc-20240409 0001932393 false 0001932393 2024-04-09 2024-04-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 9, 2024 GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)   Delaware 001-41528 88-2515116 (State or other jurisdiction of incorporation) (Commission  File Number) (IRS Employer Identification No.)       500 W. Monroe Street, Chicago, IL   60661 (Address of principal executive offices)   (Zip Code)         (Registrant’s telephone number, including area code) ( 833 ) 735-1139 ______________________________________________ (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.01 per share GEHC The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 9, 2024, Jan Makela, Chief Executive Officer, Imaging, notified GE HealthCare Technologies Inc. (the “Company”) that he will be resigning from his role at the Company to become the chief executive officer of a private company that is not one of the Company’s competitors. The Company will evaluate internal and external candidates to fill the Chief Executive Officer, Im

View on Read The Filing